Published in Cancer Epidemiol Biomarkers Prev on September 14, 2010
Breast MRI use uncommon among U.S. women. Cancer Epidemiol Biomarkers Prev (2012) 0.89
Results from a randomized trial of a web-based, tailored decision aid for women at high risk for breast cancer. Patient Educ Couns (2013) 0.83
The risk of developing invasive breast cancer in Hispanic women : a look across Hispanic subgroups. Cancer (2012) 0.82
Travel Burden to Breast MRI and Utilization: Are Risk and Sociodemographics Related? J Am Coll Radiol (2016) 0.80
Using an Internet-Based Breast Cancer Risk Assessment Tool to Improve Social-Cognitive Precursors of Physical Activity. Med Decis Making (2017) 0.75
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst (1998) 22.10
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst (1989) 19.87
American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin (2007) 12.19
Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst (2001) 5.97
Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst (1999) 5.92
A breast cancer prediction model incorporating familial and personal risk factors. Stat Med (2004) 5.30
Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst (2010) 3.94
Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst (2007) 3.93
The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions. Br J Cancer (2008) 3.87
Validation of the Gail et al. model for predicting individual breast cancer risk. J Natl Cancer Inst (1994) 3.45
Gail model for prediction of absolute risk of invasive breast cancer: independent evaluation in the Florence-European Prospective Investigation Into Cancer and Nutrition cohort. J Natl Cancer Inst (2006) 2.37
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet (2003) 2.24
Application of breast cancer risk prediction models in clinical practice. J Clin Oncol (2003) 2.19
Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med (2007) 1.94
Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst (1994) 1.69
The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Breast Cancer Res Treat (1993) 1.50
Comparing breast cancer risk assessment models. J Natl Cancer Inst (2010) 1.35
Assessing breast cancer risk: evolution of the Gail Model. J Natl Cancer Inst (2006) 1.13
Limitations of the Gail model in the specialized breast cancer risk assessment clinic. Breast J (2002) 1.11
Comparisons of two breast cancer risk estimates in women with a family history of breast cancer. Cancer Epidemiol Biomarkers Prev (2001) 1.07
The American Cancer Society guidelines for breast screening with magnetic resonance imaging: an argument for genetic testing. Cancer (2008) 1.05
Increasing accuracy of detection of breast cancer with 3-T MRI. AJR Am J Roentgenol (2009) 1.05
Converting evidence to practice: a guide for the clinical application of MRI for the screening and management of breast cancer. Eur J Cancer (2008) 0.84
Excess deaths associated with underweight, overweight, and obesity. JAMA (2005) 22.17
Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst (2004) 14.97
Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA (2007) 11.50
Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat Genet (2010) 9.07
Performance of common genetic variants in breast-cancer risk models. N Engl J Med (2010) 5.79
Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst (2006) 4.95
Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst (2011) 4.69
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA (2012) 3.85
Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst (2005) 3.75
A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet (2010) 3.53
Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst (2006) 3.36
Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J Natl Cancer Inst (2005) 3.07
Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst (2003) 3.07
The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med (2009) 2.91
Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol (2008) 2.56
A prospective study of red and processed meat intake in relation to cancer risk. PLoS Med (2007) 2.49
Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst (2003) 2.48
Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial. J Natl Cancer Inst (2009) 2.43
Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology (2002) 2.38
Gail model for prediction of absolute risk of invasive breast cancer: independent evaluation in the Florence-European Prospective Investigation Into Cancer and Nutrition cohort. J Natl Cancer Inst (2006) 2.37
Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst (2012) 2.21
Haplotype analysis in population genetics and association studies. Pharmacogenomics (2003) 2.13
Confirmation of family cancer history reported in a population-based survey. J Natl Cancer Inst (2011) 2.13
Circulating estrogens and estrogens within the breast among postmenopausal BRCA1/2 mutation carriers. Breast Cancer Res Treat (2014) 2.10
Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older. J Clin Oncol (2011) 2.00
Case-control and case-only designs with genotype and family history data: estimating relative risk, residual familial aggregation, and cumulative risk. Biometrics (2006) 1.94
Risk factor modification and projections of absolute breast cancer risk. J Natl Cancer Inst (2011) 1.94
Distribution of allele frequencies and effect sizes and their interrelationships for common genetic susceptibility variants. Proc Natl Acad Sci U S A (2011) 1.93
Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality. J Natl Cancer Inst (2012) 1.88
Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev (2003) 1.83
Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women. Cancer Epidemiol Biomarkers Prev (2010) 1.66
Cancer in Korean war navy technicians: mortality survey after 40 years. Am J Epidemiol (2002) 1.66
Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010. Breast Cancer Res Treat (2012) 1.66
Familial aggregation of Hodgkin lymphoma and related tumors. Cancer (2004) 1.60
Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J Clin Oncol (2008) 1.59
Validation of a model of lung cancer risk prediction among smokers. J Natl Cancer Inst (2006) 1.55
Correcting bias, or biased corrections? Obesity (Silver Spring) (2008) 1.54
Estrogen metabolism and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (2012) 1.53
Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men. J Natl Cancer Inst (2005) 1.51
Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. J Natl Cancer Inst (2011) 1.51
Impact of smoking and preexisting illness on estimates of the fractions of deaths associated with underweight, overweight, and obesity in the US population. Am J Epidemiol (2007) 1.46
Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration. J Clin Epidemiol (2011) 1.46
Assessment of the human faecal microbiota: II. Reproducibility and associations of 16S rRNA pyrosequences. Eur J Clin Invest (2012) 1.43
Using cases to strengthen inference on the association between single nucleotide polymorphisms and a secondary phenotype in genome-wide association studies. Genet Epidemiol (2010) 1.43
Average midrange ultraviolet radiation flux and time outdoors predict melanoma risk. Cancer Res (2002) 1.42
Prevalence and correlates of repeat mammography among women aged 55-79 in the Year 2000 National Health Interview Survey. Prev Med (2004) 1.39
Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research. Genet Med (2012) 1.39
What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a U.S. National Survey. Cancer Epidemiol Biomarkers Prev (2004) 1.36
Awareness of genetic testing for increased cancer risk in the year 2000 National Health Interview Survey. Community Genet (2003) 1.36
Comparing breast cancer risk assessment models. J Natl Cancer Inst (2010) 1.35
Sample size calculations for population- and family-based case-control association studies on marker genotypes. Genet Epidemiol (2003) 1.34
Communication of uncertainty regarding individualized cancer risk estimates: effects and influential factors. Med Decis Making (2010) 1.33
Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population. Pharmacoepidemiol Drug Saf (2013) 1.33
Increasing breast cancer incidence in China: the numbers add up. J Natl Cancer Inst (2008) 1.32
Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions. Cancer Causes Control (2007) 1.28
Estimation of attributable number of deaths and standard errors from simple and complex sampled cohorts. Stat Med (2007) 1.26
Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California Health Interview Survey. Genet Med (2010) 1.26
Helicobacter pylori infection in rural China: demographic, lifestyle and environmental factors. Int J Epidemiol (2002) 1.26
Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancer. Cancer Causes Control (2011) 1.25
Postdiagnosis diet quality is inversely related to a biomarker of inflammation among breast cancer survivors. Cancer Epidemiol Biomarkers Prev (2010) 1.25
Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts. Cancer Causes Control (2010) 1.21
Potential usefulness of single nucleotide polymorphisms to identify persons at high cancer risk: an evaluation of seven common cancers. J Clin Oncol (2012) 1.15
Haplotype-based regression analysis and inference of case-control studies with unphased genotypes and measurement errors in environmental exposures. Biometrics (2007) 1.15
Laypersons' responses to the communication of uncertainty regarding cancer risk estimates. Med Decis Making (2009) 1.15
Population sciences, translational research, and the opportunities and challenges for genomics to reduce the burden of cancer in the 21st century. Cancer Epidemiol Biomarkers Prev (2011) 1.13
Conceptual problems in laypersons' understanding of individualized cancer risk: a qualitative study. Health Expect (2009) 1.12
Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies. PLoS Med (2013) 1.11
Efficiency of DNA pooling to estimate joint allele frequencies and measure linkage disequilibrium. Genet Epidemiol (2002) 1.10
Diet and stomach cancer risk in Warsaw, Poland. Nutr Cancer (2004) 1.09
Genome-based prediction of breast cancer risk in the general population: a modeling study based on meta-analyses of genetic associations. Cancer Epidemiol Biomarkers Prev (2011) 1.09
Garlic, vitamin, and antibiotic treatment for Helicobacter pylori: a randomized factorial controlled trial. Helicobacter (2007) 1.08
Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research. J Natl Cancer Inst (2012) 1.04
Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma. Clin Cancer Res (2005) 1.03
Beyond recreational physical activity: examining occupational and household activity, transportation activity, and sedentary behavior in relation to postmenopausal breast cancer risk. Am J Public Health (2010) 1.03
Relationships between computer-extracted mammographic texture pattern features and BRCA1/2 mutation status: a cross-sectional study. Breast Cancer Res (2014) 1.02
Efficient adaptively weighted analysis of secondary phenotypes in case-control genome-wide association studies. Hum Hered (2012) 1.01
Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer. Breast Cancer Res Treat (2010) 1.00
Evaluating breast cancer risk projections for Hispanic women. Breast Cancer Res Treat (2011) 0.99
Prevalence of hepatitis C virus infection and risk for hepatocellular carcinoma and non-Hodgkin lymphoma in AIDS. J Acquir Immune Defic Syndr (2002) 0.99
Comparison of asbestos exposure assessments by next-of-kin respondents, by an occupational hygienist, and by a job-exposure matrix from the National Occupational Hazard Survey. Am J Ind Med (2005) 0.99
Estimating the variance of disease-prevalence estimates from population-based registries. Biometrics (2002) 0.98
Representing randomness in the communication of individualized cancer risk estimates: effects on cancer risk perceptions, worry, and subjective uncertainty about risk. Patient Educ Couns (2011) 0.98
Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects. J Natl Cancer Inst (2013) 0.98
Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China. Carcinogenesis (2013) 0.97
Frontiers in cancer epidemiology: a challenge to the research community from the Epidemiology and Genomics Research Program at the National Cancer Institute. Cancer Epidemiol Biomarkers Prev (2012) 0.97
Long-term survival among patients with Hodgkin's lymphoma who developed breast cancer: a population-based study. J Clin Oncol (2010) 0.96
Correlates of unrealistic risk beliefs in a nationally representative sample. J Behav Med (2010) 0.95
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration. Eur J Epidemiol (2011) 0.94
Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study. J Transl Med (2012) 0.94
Weight-associated deaths in the United States. J Womens Health (Larchmt) (2007) 0.94
Breast-cancer risk in BRCA-mutation-negative women from BRCA-mutation-positive families. Lancet Oncol (2007) 0.94
Assessment of the human faecal microbiota: I. Measurement and reproducibility of selected enzymatic activities. Eur J Clin Invest (2012) 0.92
Piecewise exponential survival times and analysis of case-cohort data. Stat Med (2012) 0.92
Absolute risk models for subtypes of breast cancer. J Natl Cancer Inst (2007) 0.91
Physician exposure to and attitudes toward advertisements for genetic tests for inherited cancer susceptibility. Am J Med Genet A (2005) 0.91
Novel adverse events of bevacizumab in the US FDA adverse event reporting system database: a disproportionality analysis. Drug Saf (2012) 0.90
Sources of differences in estimates of obesity-associated deaths from first National Health and Nutrition Examination Survey (NHANES I) hazard ratios. Am J Clin Nutr (2010) 0.90
Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival. Cancer Res (2009) 0.90
A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins. Am J Clin Nutr (2006) 0.90